Syntegon Pharmatag 2025: enabling collaborative success
27/05/2025 Syntegon Technology GmbH (formerlyBosch Packaging)
- 10th edition of Pharmatag with record participation
- World premiere of SynTiso: innovative line concept for liquid pharmaceutical filling
- Program presents latest innovations and successful, collaborative partnerships
On May 20 and 21, 2025, Syntegon, a leading strategic partner to the global pharmaceutical, biotech, and food industries, hosted the 10th edition of its industry-leading Pharmatag. A record number of more than 350 global customers, partners, innovators, and leaders accepted Syntegon’s invitation to join the event.
“Close collaboration between customers and technology providers is more important than ever – especially when developing mission-critical solutions for the pharmaceutical and biotech industries,” said Torsten Türling, CEO of the Syntegon Group. “The many successful examples shared at Pharmatag clearly demonstrate this. What truly sets Syntegon apart is our unwavering commitment to partnership.”
Enabling collaborative success
The program featured a wide range of the latest innovations, expert insights, and real-world success stories. Among the highlights were the keynote speeches by Brigitte Reutter-Haerle, VP Product Management at Vetter Pharma, and Christa Myers, Process Chemical Engineer at CRB. Both emphasized the importance of collaboration today to shape the future of the pharmaceutical industry.Case studies presented by Siegfried Hameln, GennVax, Lek d.d., Stevanato Group, and Aspen demonstrated how co-creation is already delivering tangible results. In addition, a behind-the-scenes look at Syntegon’s production gave attendees the opportunity to explore innovative machine concepts and bespoke customer projects firsthand.
World premiere of innovative new line concept SynTiso
The world premiere of the innovative line concept SynTiso revealed at Pharmatag exemplifies Syntegon’s new strategy, which focuses on growth, operational excellence, and long-term value creation. This strategy aims to build better businesses through seamless processes, provide customers with access to the most innovative technologies, and lead the market through sustainable solutions that stand the test of time.
The SynTiso line concept for liquid pharmaceutical filling was developed in close collaboration with two partners from the pharmaceutical industry. SynTiso addresses the current challenges faced by pharmaceutical manufacturers, who require high availability and full automation as well as maximum product yield and minimal operator intervention. “Together with our customers, we will revolutionize liquid filling,” says Stephan März, Executive VP Pharma Liquid at Syntegon.
Print this articleFor more information, please contact:
Patrick Loeffel
Syntegon Technology GmbH (formerlyBosch Packaging)
Postfach 10 60 50
Stuttgarter Strasse 130
71332 Waiblingen
D-70049
Germany
Tel: +49 7151 14-0
Email: marketing@syntegon.com
Web: https://www.syntegon.com
Share article:
Process and Control Today are not responsible for the content of submitted or externally produced articles and images. Click here to email us about any errors or omissions contained within this article.